Related Experiment Videos
Detection of platelet-activating factor during traumatic shock.
G L Stahl1, D V Craft, P H Lento
1Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.
Circulatory Shock
|November 1, 1988
Summary
Platelet-activating factor (PAF) is formed in rats experiencing traumatic shock. This phospholipid aggregation of platelets suggests PAF
Area of Science:
- Biochemistry
- Physiology
- Pharmacology
Background:
- Traumatic shock is a critical condition with complex pathophysiological mechanisms.
- Platelet-activating factor (PAF) is a potent lipid mediator implicated in inflammatory and immune responses.
Purpose of the Study:
- To investigate the formation of platelet-activating factor (PAF) in peritoneal fluid following traumatic shock in rats.
- To determine the functional role of PAF in the pathogenesis of traumatic shock.
Main Methods:
- Induction of traumatic shock in rats using Noble-Collip drum trauma.
- Analysis of peritoneal fluid using high-performance liquid chromatography (HPLC).
- Assessment of platelet aggregation in response to peritoneal fluid extracts and blockade with a specific PAF receptor antagonist (CV-6209).
Main Results:
- Peritoneal fluid from traumatized rats contained a phospholipid with HPLC retention time similar to authentic PAF, absent in control rats.
- Peritoneal fluid extracts from traumatized rats induced significant aggregation of washed rabbit platelets.
- PAF receptor antagonist CV-6209 blocked the platelet aggregation induced by these extracts.
- Platelet aggregation activity in peritoneal fluid increased nearly four-fold in traumatized rats compared to sham-shock controls.
Conclusions:
- Findings are consistent with the formation of platelet-activating factor (PAF) during traumatic shock in rats.
- The data support a significant role for PAF in the pathogenesis of traumatic shock, evidenced by its formation and platelet-aggregating activity.